This opportunity funds advanced pre-clinical research to translate nanotechnology-based cancer diagnostics and therapeutics. It supports maturation of experimental nanomedicines using nanoparticles and nano-devices designed to enhance cancer treatment effectiveness. The goal is to advance these interventions toward further translational development programs such as NCI Experimental Therapeutics (NExT). Clinical trials are not allowed under this award.
Eligible applicants include a wide range of U.S. organizations such as federally recognized Native American tribal governments, for-profit organizations, state and local governments, nonprofits, small businesses, and institutions of higher education. Specific eligibility details are provided in the
